Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-10 21:35:21 UTC |
---|
Update Date | 2021-09-26 22:52:10 UTC |
---|
HMDB ID | HMDB0244429 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | N-[(3R)-2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-N'-(3-methylphenyl)urea |
---|
Description | N-[(3R)-2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-N'-(3-methylphenyl)urea, also known as N-(1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-3-yl)-n'-(3-methylphenyl)carbamimidate, belongs to the class of organic compounds known as 1,4-benzodiazepines. These are organic compounds containing a benzene ring fused to a 1,4-azepine. Based on a literature review very few articles have been published on N-[(3R)-2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-N'-(3-methylphenyl)urea. This compound has been identified in human blood as reported by (PMID: 31557052 ). N-[(3r)-2,3-dihydro-1-methyl-2-oxo-5-phenyl-1h-1,4-benzodiazepin-3-yl]-n'-(3-methylphenyl)urea is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically N-[(3R)-2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-N'-(3-methylphenyl)urea is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | CN1C2=CC=CC=C2C(=NC(NC(=O)NC2=CC=CC(C)=C2)C1=O)C1=CC=CC=C1 InChI=1S/C24H22N4O2/c1-16-9-8-12-18(15-16)25-24(30)27-22-23(29)28(2)20-14-7-6-13-19(20)21(26-22)17-10-4-3-5-11-17/h3-15,22H,1-2H3,(H2,25,27,30) |
---|
Synonyms | Value | Source |
---|
N-(1-Methyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-3-yl)-n'-(3-methylphenyl)carbamimidate | HMDB |
|
---|
Chemical Formula | C24H22N4O2 |
---|
Average Molecular Weight | 398.466 |
---|
Monoisotopic Molecular Weight | 398.174275964 |
---|
IUPAC Name | 1-(1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-3-yl)-3-(3-methylphenyl)urea |
---|
Traditional Name | 1-(1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl)-3-(3-methylphenyl)urea |
---|
CAS Registry Number | Not Available |
---|
SMILES | CN1C2=CC=CC=C2C(=NC(NC(=O)NC2=CC=CC(C)=C2)C1=O)C1=CC=CC=C1 |
---|
InChI Identifier | InChI=1S/C24H22N4O2/c1-16-9-8-12-18(15-16)25-24(30)27-22-23(29)28(2)20-14-7-6-13-19(20)21(26-22)17-10-4-3-5-11-17/h3-15,22H,1-2H3,(H2,25,27,30) |
---|
InChI Key | KDFQABSFVYLGPM-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as 1,4-benzodiazepines. These are organic compounds containing a benzene ring fused to a 1,4-azepine. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Benzodiazepines |
---|
Sub Class | 1,4-benzodiazepines |
---|
Direct Parent | 1,4-benzodiazepines |
---|
Alternative Parents | |
---|
Substituents | - 1,4-benzodiazepine
- Alpha-amino acid or derivatives
- N-phenylurea
- Toluene
- Monocyclic benzene moiety
- Benzenoid
- Tertiary carboxylic acid amide
- Urea
- Carboxamide group
- Ketimine
- Lactam
- Carbonic acid derivative
- Organic 1,3-dipolar compound
- Propargyl-type 1,3-dipolar organic compound
- Azacycle
- Carboxylic acid derivative
- Hydrocarbon derivative
- Organopnictogen compound
- Organonitrogen compound
- Organooxygen compound
- Imine
- Organic nitrogen compound
- Organic oxide
- Carbonyl group
- Organic oxygen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Not Available | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
N-[(3R)-2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-N'-(3-methylphenyl)urea,1TMS,isomer #1 | CC1=CC=CC(NC(=O)N(C2N=C(C3=CC=CC=C3)C3=CC=CC=C3N(C)C2=O)[Si](C)(C)C)=C1 | 3527.8 | Semi standard non polar | 33892256 | N-[(3R)-2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-N'-(3-methylphenyl)urea,1TMS,isomer #1 | CC1=CC=CC(NC(=O)N(C2N=C(C3=CC=CC=C3)C3=CC=CC=C3N(C)C2=O)[Si](C)(C)C)=C1 | 3308.8 | Standard non polar | 33892256 | N-[(3R)-2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-N'-(3-methylphenyl)urea,1TMS,isomer #1 | CC1=CC=CC(NC(=O)N(C2N=C(C3=CC=CC=C3)C3=CC=CC=C3N(C)C2=O)[Si](C)(C)C)=C1 | 5171.1 | Standard polar | 33892256 | N-[(3R)-2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-N'-(3-methylphenyl)urea,1TMS,isomer #2 | CC1=CC=CC(N(C(=O)NC2N=C(C3=CC=CC=C3)C3=CC=CC=C3N(C)C2=O)[Si](C)(C)C)=C1 | 3380.1 | Semi standard non polar | 33892256 | N-[(3R)-2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-N'-(3-methylphenyl)urea,1TMS,isomer #2 | CC1=CC=CC(N(C(=O)NC2N=C(C3=CC=CC=C3)C3=CC=CC=C3N(C)C2=O)[Si](C)(C)C)=C1 | 3333.6 | Standard non polar | 33892256 | N-[(3R)-2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-N'-(3-methylphenyl)urea,1TMS,isomer #2 | CC1=CC=CC(N(C(=O)NC2N=C(C3=CC=CC=C3)C3=CC=CC=C3N(C)C2=O)[Si](C)(C)C)=C1 | 5006.8 | Standard polar | 33892256 | N-[(3R)-2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-N'-(3-methylphenyl)urea,2TMS,isomer #1 | CC1=CC=CC(N(C(=O)N(C2N=C(C3=CC=CC=C3)C3=CC=CC=C3N(C)C2=O)[Si](C)(C)C)[Si](C)(C)C)=C1 | 3374.7 | Semi standard non polar | 33892256 | N-[(3R)-2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-N'-(3-methylphenyl)urea,2TMS,isomer #1 | CC1=CC=CC(N(C(=O)N(C2N=C(C3=CC=CC=C3)C3=CC=CC=C3N(C)C2=O)[Si](C)(C)C)[Si](C)(C)C)=C1 | 3305.7 | Standard non polar | 33892256 | N-[(3R)-2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-N'-(3-methylphenyl)urea,2TMS,isomer #1 | CC1=CC=CC(N(C(=O)N(C2N=C(C3=CC=CC=C3)C3=CC=CC=C3N(C)C2=O)[Si](C)(C)C)[Si](C)(C)C)=C1 | 4631.8 | Standard polar | 33892256 | N-[(3R)-2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-N'-(3-methylphenyl)urea,1TBDMS,isomer #1 | CC1=CC=CC(NC(=O)N(C2N=C(C3=CC=CC=C3)C3=CC=CC=C3N(C)C2=O)[Si](C)(C)C(C)(C)C)=C1 | 3707.5 | Semi standard non polar | 33892256 | N-[(3R)-2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-N'-(3-methylphenyl)urea,1TBDMS,isomer #1 | CC1=CC=CC(NC(=O)N(C2N=C(C3=CC=CC=C3)C3=CC=CC=C3N(C)C2=O)[Si](C)(C)C(C)(C)C)=C1 | 3508.1 | Standard non polar | 33892256 | N-[(3R)-2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-N'-(3-methylphenyl)urea,1TBDMS,isomer #1 | CC1=CC=CC(NC(=O)N(C2N=C(C3=CC=CC=C3)C3=CC=CC=C3N(C)C2=O)[Si](C)(C)C(C)(C)C)=C1 | 5096.5 | Standard polar | 33892256 | N-[(3R)-2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-N'-(3-methylphenyl)urea,1TBDMS,isomer #2 | CC1=CC=CC(N(C(=O)NC2N=C(C3=CC=CC=C3)C3=CC=CC=C3N(C)C2=O)[Si](C)(C)C(C)(C)C)=C1 | 3587.4 | Semi standard non polar | 33892256 | N-[(3R)-2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-N'-(3-methylphenyl)urea,1TBDMS,isomer #2 | CC1=CC=CC(N(C(=O)NC2N=C(C3=CC=CC=C3)C3=CC=CC=C3N(C)C2=O)[Si](C)(C)C(C)(C)C)=C1 | 3540.3 | Standard non polar | 33892256 | N-[(3R)-2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-N'-(3-methylphenyl)urea,1TBDMS,isomer #2 | CC1=CC=CC(N(C(=O)NC2N=C(C3=CC=CC=C3)C3=CC=CC=C3N(C)C2=O)[Si](C)(C)C(C)(C)C)=C1 | 4985.6 | Standard polar | 33892256 | N-[(3R)-2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-N'-(3-methylphenyl)urea,2TBDMS,isomer #1 | CC1=CC=CC(N(C(=O)N(C2N=C(C3=CC=CC=C3)C3=CC=CC=C3N(C)C2=O)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C1 | 3730.0 | Semi standard non polar | 33892256 | N-[(3R)-2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-N'-(3-methylphenyl)urea,2TBDMS,isomer #1 | CC1=CC=CC(N(C(=O)N(C2N=C(C3=CC=CC=C3)C3=CC=CC=C3N(C)C2=O)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C1 | 3715.2 | Standard non polar | 33892256 | N-[(3R)-2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-N'-(3-methylphenyl)urea,2TBDMS,isomer #1 | CC1=CC=CC(N(C(=O)N(C2N=C(C3=CC=CC=C3)C3=CC=CC=C3N(C)C2=O)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C1 | 4645.7 | Standard polar | 33892256 |
| Show more...
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - N-[(3R)-2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-N'-(3-methylphenyl)urea GC-MS (Non-derivatized) - 70eV, Positive | splash10-0a4i-0925000000-26579f8c3862a2f8412c | 2021-09-23 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - N-[(3R)-2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-N'-(3-methylphenyl)urea GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - N-[(3R)-2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-N'-(3-methylphenyl)urea GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-[(3R)-2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-N'-(3-methylphenyl)urea 10V, Positive-QTOF | splash10-0002-0039000000-3d0630439847be5d835d | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-[(3R)-2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-N'-(3-methylphenyl)urea 20V, Positive-QTOF | splash10-0005-0192000000-79c6a49fd9e2af4a9a8b | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-[(3R)-2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-N'-(3-methylphenyl)urea 40V, Positive-QTOF | splash10-052g-7971000000-f26982497f57d831c2fc | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-[(3R)-2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-N'-(3-methylphenyl)urea 10V, Negative-QTOF | splash10-0002-0229000000-64ee1cdd9f573a1c7652 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-[(3R)-2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-N'-(3-methylphenyl)urea 20V, Negative-QTOF | splash10-0a4i-0941000000-02c8b9d02edc98e19133 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-[(3R)-2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-N'-(3-methylphenyl)urea 40V, Negative-QTOF | splash10-0a4i-2490000000-f7fc4f18cc38f08e66d0 | 2021-10-12 | Wishart Lab | View Spectrum |
| Show more...
---|
Biological Properties |
---|
Cellular Locations | Not Available |
---|
Biospecimen Locations | |
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Detected but not Quantified | Not Quantified | Not Specified | Not Specified | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| Not Available |
---|
Associated Disorders and Diseases |
---|
Disease References | None |
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | Not Available |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 94692 |
---|
KEGG Compound ID | Not Available |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Not Available |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 104929 |
---|
PDB ID | Not Available |
---|
ChEBI ID | Not Available |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]
|
---|